Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. This technology aims to reduce mortality and limb loss associated with acute cardiovascular events.
Funding
$180K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
FVFounders
Product
Problem
Type B aortic dissections are complex cardiovascular conditions that can lead to life-threatening complications, including mortality and limb loss. Early detection and intervention are critical, but predicting which patients are most at risk remains a challenge.
Solution
Voythos is developing multimodal machine learning models to predict life-threatening complications in Type B aortic dissections, enabling earlier intervention by cardiovascular surgeons. The technology analyzes diverse data inputs to identify patients at high risk of acute cardiovascular events. By providing clinicians with predictive insights, Voythos aims to reduce mortality and limb loss associated with these dissections. The company is currently in the development phase and not yet selling its services.
Target Audience
The primary target audience is cardiovascular surgeons and medical professionals involved in the treatment of Type B aortic dissections.
Features
- Multimodal machine learning models for risk prediction
- Analysis of diverse data inputs to identify high-risk patients
- Predictive insights to enable earlier intervention